This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Oct;56(4):606-8.

doi: 10.1016/j.eururo.2009.07.015. Epub 2009 Jul 22.

Recent progress and pitfalls in testing novel agents in castration-resistant prostate cancer

Joaquim Bellmunt, Jonathan E Rosenberg, Toni K Choueiri

PMID: 19635642
DOI: 10.1016/j.eururo.2009.07.015

Editorial

Recent progress and pitfalls in testing novel agents in castration-resistant prostate cancer

Joaquim Bellmunt et al. Eur Urol. 2009 Oct.

. 2009 Oct;56(4):606-8.

doi: 10.1016/j.eururo.2009.07.015. Epub 2009 Jul 22.

Authors

Joaquim Bellmunt, Jonathan E Rosenberg, Toni K Choueiri

PMID: 19635642
DOI: 10.1016/j.eururo.2009.07.015

No abstract available

PubMed Disclaimer

Comment on

Castration-resistant prostate cancer: from new pathophysiology to new treatment targets.
Chi KN, Bjartell A, Dearnaley D, Saad F, Schröder FH, Sternberg C, Tombal B, Visakorpi T. Chi KN, et al. Eur Urol. 2009 Oct;56(4):594-605. doi: 10.1016/j.eururo.2009.06.027. Epub 2009 Jun 24. Eur Urol. 2009. PMID: 19560857 Review.

Similar articles

Castration-resistant prostate cancer: descriptive yet pejorative?
Crawford ED, Petrylak D. Crawford ED, et al. J Clin Oncol. 2010 Aug 10;28(23):e408. doi: 10.1200/JCO.2010.28.7664. Epub 2010 Jun 14. J Clin Oncol. 2010. PMID: 20547989 No abstract available.
Castration-resistant prostate cancer--hormone therapy redux.
Tolcher AW, Cooper J. Tolcher AW, et al. J Clin Oncol. 2010 Mar 20;28(9):1447-9. doi: 10.1200/JCO.2009.25.3781. Epub 2010 Feb 16. J Clin Oncol. 2010. PMID: 20159817 No abstract available.
Nilutamide response after flutamide failure in post-orchiectomy progressive prostate cancer.
Eastham JA, Sartor O. Eastham JA, et al. J Urol. 1998 Mar;159(3):990. J Urol. 1998. PMID: 9474206 No abstract available.
Continued targeting of androgen receptor signalling: a rational and efficacious therapeutic strategy in metastatic castration-resistant prostate cancer.
Bianchini D, de Bono JS. Bianchini D, et al. Eur J Cancer. 2011 Sep;47 Suppl 3:S189-94. doi: 10.1016/S0959-8049(11)70164-2. Eur J Cancer. 2011. PMID: 21943974 Review. No abstract available.
Physiologic basis of endocrine therapy for prostatic cancer.
McConnell JD. McConnell JD. Urol Clin North Am. 1991 Feb;18(1):1-13. Urol Clin North Am. 1991. PMID: 1899494 Review.

See all similar articles

Cited by

Castration-resistant prostate cancer: new science and therapeutic prospects.
Bellmunt J, Oh WK. Bellmunt J, et al. Ther Adv Med Oncol. 2010 May;2(3):189-207. doi: 10.1177/1758834009359769. Ther Adv Med Oncol. 2010. PMID: 21789134 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information